Statin use and survival in CLL/SLL treated with ibrutinib: pooled analysis of 4 randomized controlled trials

Abstract: Patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) have seen significant treatment advancements with the emergence of Bruton tyrosine kinase inhibitors like ibrutinib. Statin use has been linked to reduced mortality in several cancers, including CLL. Howe...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Ahmad Y. Abuhelwa, Sara A. Almansour, Jennifer R. Brown, Humaid O. Al-Shamsi, Ziad Abuhelwa, Zelal Kharaba, Yasser Bustanji, Mohammad H. Semreen, Salma Ali, Ahmad Alhuraiji, Ross A. McKinnon, Michael J. Sorich, Karem H. Alzoubi, Ashley M. Hopkins
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Elsevier 2025-07-01
Σειρά:	Blood Advances
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S2473952925002435
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!